PHAS PhaseBio Pharmaceuticals Inc

PhaseBio to Present at Stifel 2019 Healthcare Conference

PhaseBio to Present at Stifel 2019 Healthcare Conference

MALVERN, Pa. and SAN DIEGO, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow will present a company overview at the Stifel 2019 Healthcare Conference on Tuesday, November 19, at 10:20 a.m. EST at the Lotte New York Palace Hotel in New York, NY.

The event will be available via live webcast from the “Events and Presentations” page of the “Investors” section of the company’s website at The webcast replay will be available for 90 days after the conclusion of the live presentation.

About PhaseBio

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat cardiopulmonary diseases. The company’s lead development candidate is PB2452, a novel reversal agent for the antiplatelet therapy ticagrelor. PhaseBio is also leveraging its proprietary elastin-like polypeptide (“ELP”) technology platform to develop therapies with the potential for less-frequent dosing and improved pharmacokinetics. PhaseBio’s second product candidate PB1046, which is based on ELP, is a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension.

PhaseBio is located in Malvern, PA and San Diego, CA. For more information, please visit .

Investor Contact:

John Sharp

PhaseBio Pharmaceuticals, Inc.

Chief Financial Officer

(610) 981-6506

Media Contact:

Gina Cestari

6 Degrees

(917) 797-7904

 

EN
15/11/2019

Underlying

PHASPhaseBio Pharmaceuticals Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PhaseBio Pharmaceuticals Inc

Jonathan Moreland
  • Jonathan Moreland
Free Trial
WOR Worthington Ind...
VCYT VERACYTE INC ... (+53)

InsiderInsights Weekly Report: October 29, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

WOR WORTHINGTON INDUSTRIES INC.
VCYT VERACYTE INC
TCBI TEXAS CAPITAL BANCSHARES INC.
STRM STREAMLINE HEALTH SOLUTIONS
SBSI SOUTHSIDE BANCSHARES INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OPK OPKO HEALTH INC.
MGNX MACROGENICS INC.
HBAN HUNTINGTON BANCSHARES INCORPORATED
FITB FIFTH THIRD BANCORP
FFIN FIRST FINANCIAL BANKSHARES INC
FAST FASTENAL COMPANY
FARM FARMER BROS. CO.
AZZ AZZ INC.
ANGO ANGIODYNAMICS INC.
AHH ARMADA HOFFLER PROPERTIES INC.
EVA ENVIVA PARTNERS LP
BSET BASSETT FURNITURE INDUSTRIES INC.
CCI CROWN CASTLE INTERNATIONAL CORP
THO THOR INDUSTRIES INC.
IGR CBRE CLARION GLOBAL REAL ESTAT
INBK FIRST INTERNET BANCORP
FONR FONAR CORP.
PLSE PULSE BIOSCIENCES
NTIC NORTHERN TECHNOLOGIES INTERNATIONAL
FBK FB FINANCIAL CORPORATION
CDXC CHROMADEX CORP
SNAP SNAP INC. CLASS A
QNST QUINSTREET
RCKT ROCKET PHARMACEUTICALS
INSP INSPIRE MEDICAL SYSTEMS
GIM TEMPLETON GLOBAL INCOME FUND
BOTJ BANK OF THE JAMES FINANCIAL GROUP INC.
SRRK SCHOLAR ROCK HOLDING CORPORATION
FUND ROYCE FOCUS TRUST
PHAS INC.
NGM PHASEBIO PHARMACEUTICALS INC
OTLK NGM BIOPHARMACEUTICALS
DX OUTLOOK THERAPEUTICS
AXLA DYNEX CAPITAL INC.
CABA AXCELLA HEALTH
NREF CABALETTA BIO
BDTX NEXPOINT REAL ESTATE FINANCE
NKLA INC.
IMRA BLACK DIAMOND THERAPEUTICS
BYRN INC.
EPIX NIKOLA CORPORATION
TNGX IMARA
APLD BYRNA TECHNOLOGIES INC
LEXX EPIX PHARMACEUTICALS
TANGO THERAPEUTICS INC
APPLIED BLOCKCHAIN INC
LEXARIA BIOSCIENCE CORP
10/29/22 October 29, 2022 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
RMAX RE/MAX Holdings...
FFIN First Financial... ... (+7)

InsiderInsights Daily Ratings Report: October 26, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

RMAX RE/MAX HOLDINGS INC.
FFIN FIRST FINANCIAL BANKSHARES INC
INBK FIRST INTERNET BANCORP
SNAP SNAP INC. CLASS A
PHAS PHASEBIO PHARMACEUTICALS INC
RKT ROCKET SHARING COMPANY SPA
APLD APPLIED BLOCKCHAIN INC
10/27/22 October 27, 2022 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
ZIOP ZIOPHARM Oncolo...
VRAY VIEWRAY INC. ... (+60)

InsiderInsights Weekly Tables: September 4, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ZIOP ZIOPHARM ONCOLOGY INC.
VRAY VIEWRAY INC.
SXT SENSIENT TECHNOLOGIES CORPORATION
SPNE SEASPINE HOLDINGS CORP.
REGI RENEWABLE ENERGY GROUP INC.
PAHC PHIBRO ANIMAL HEALTH CORPORATION CLASS A
OGE OGE ENERGY CORP.
NRIM NORTHRIM BANCORP INC.
NGL NGL ENERGY PARTNERS LP
FMNB FARMERS NATIONAL BANC CORP.
CRMT AMERICA'S CAR-MART INC.
VAL VALOR RESOURCES
AMTX AEMETIS
PBHC PATHFINDER BANCORP INC.
RMCF ROCKY MOUNTAIN CHOCOLATE FACTORY INC.
MYOV MYOVANT SCIENCE
RFL RAFAEL HOLDINGS CL B
FDEU FIRST TRUST DYNAMIC EUROPE EQUITY INCOME FUND
FUND ROYCE FOCUS TRUST
PFIS INC.
WLMS PEOPLES FINANCIAL SERVICES CORP.
PHAS WILLIAMS INDUSTRIAL SERVICES GROUP INC.
STIM PHASEBIO PHARMACEUTICALS INC
KTB STIMSONITE CORP
NLTX KONTOOR BRANDS
RMBI NEOLEUKIN THERAPEUTICS
GDRX RICHMOND MUTUAL BANCORPORATION
ATCX INC.
LUMO GOODRX HOLDINGS
CPE INC.
CERE ATLAS TECHNICAL CONSULTANTS INC (A)
SLQT LUMOS PHARMA INC.
HOFV CALLON PETROLEUM
AM CEREVEL THERAPEUTICS HOLDINGS (A)
HIMS SELECTQUOTE
UAN INC.
PFX HALL OF FAME RESORT AND ENTERTAINMENT COMPANY (A)
VYNT ANTERO MIDSTREAM CORP.
RPHM HIMS AND HERS HEALTH INC (A)
REPX CVR PARTNERS LP
DIBS PHENIXFIN CORP
BMEA VYANT BIO
UP INC.
HUMA RENEO PHARMACEUTICALS
AUID INC.
FSBC RILEY EXPLORATION PERMIAN
LGIQ INC.
IVFH 1STDIBS.COM
BTTR INC.
LOWLF BIOMEA FUSION
INC.
WHEELS UP EXPERIENCE INC.
HUMAN CARE HC AB
IPSIDY INC.
FIVE STAR BANCORP
LOGIQ
INC.
INNOVATIVE FOOD HLDG
BETTER CHOICE CO INC.
LOWELL FARMS INC.
09/04/21 September 4, 2021 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
NGL NGL Energy Part...
CRMT America's Car-M... ... (+17)

InsiderInsights Daily Ratings Report: August 30, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

NGL NGL ENERGY PARTNERS LP
CRMT AMERICA'S CAR-MART INC.
BCOV BRIGHTCOVE
SCOR COMSCORE INC.
PBHC PATHFINDER BANCORP INC.
MYOV MYOVANT SCIENCE
PHAS PHASEBIO PHARMACEUTICALS INC
KFS KINGSWAY FINANCIAL SERVICES
IMVT IMMUNOVANT INC
ATCX ATLAS TECHNICAL CONSULTANTS INC (A)
SLQT SELECTQUOTE
HIMS INC.
REPX HIMS AND HERS HEALTH INC (A)
AUID RILEY EXPLORATION PERMIAN
IVFH INC.
IPSIDY INC.
INNOVATIVE FOOD HLDG
08/31/21 August 31, 2021 1 EN
 PRESS RELEASE
Free
PHAS PhaseBio Pharma...

PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results a...

PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights Recently Initiated PB2452 Phase 3 Trial for the Reversal of the Antiplatelet Effects of Ticagrelor Received FDA Breakthrough Therapy Designation and EMA PRIME Designation for PB2452 Secured PB2452 Financing and Co-Development Collaboration with SFJ Pharmaceuticals® MALVERN, Pa. and SAN DIEGO, March 30, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary disea...

March 30, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch